19/05/2009 : World Hepatitis Day at Echosens.
14/05/2009: The HAS (French Health High Authority) enlarges the FibroScan® indication.
To nourish its innovation, Echosens is involved in numerous partnerships.
"Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B."
With the paediatric probe, you can now expand your diagnostic horizons.
Echosens defines itself as a socially aware company, by being an active actor in the education and social domains, as much at the local level as the international level.
